Apoptosis induces Bcl-XS and cleaved Bcl-XL in chronic lymphocytic leukaemia

Biochemical and Biophysical Research Communications

Volumn 405, Issue 3, 2011, Pages 480-485

  Willimott, Shaun ^a   Merriam, Thomas ^a   Wagner, Simon D ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Apoptosis; Bcl XL; Bcl XS; Chronic lymphocytic leukaemia

Indexed keywords

CASPASE 3; CD40 ANTIGEN; EMETINE; INTERLEUKIN 4; PROTEIN BCL X; PROTEIN BCL XL; PROTEIN BCL XS; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B CELL LEUKEMIA; CELL DEATH; FEMALE; FIBROBLAST; HUMAN; HUMAN TISSUE; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; ANIMALS; APOPTOSIS; BCL-X PROTEIN; CASPASES; CD40 LIGAND; EMETINE; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MICE; MIDDLE AGED; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 79951578014     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.01.057     Document Type: Article

References (28)

1. Burger J.A., Ghia P., Rosenwald A., Caligaris-Cappio F. The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood 2009, 114:3367-3375.
2. Burger J.A., Tsukada N., Burger M., Zvaifler N.J., Dell'Aquila M., Kipps T.J. Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. Blood 2000, 96:2655-2663.
3. Kurtova A.V., Balakrishnan K., Chen R., Ding W., Schnabl S., Quiroga M.P., Sivina M., Wierda W.G., Estrov Z., Keating M.J., Shehata M., Jager U., Gandhi V., Kay N.E., Plunkett W., Burger J.A. Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance. Blood 2009, 114:4441-4450.
4. Willimott S., Baou M., Huf S., Deaglio S., Wagner S.D. Regulation of CD38 in proliferating chronic lymphocytic leukemia cells stimulated with CD154 and interleukin-4. Haematologica 2007, 92:1359-1366.
5. Willimott S., Baou M., Huf S., Wagner S.D. Separate cell culture conditions to promote proliferation or quiescent cell survival in chronic lymphocytic leukemia. Leuk. Lymphoma 2007, 48:1647-1650.
6. Willimott S., Baou M., Naresh K., Wagner S.D. CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia. Br. J. Haematol. 2007, 138:721-732.
7. Vogler M., Butterworth M., Majid A., Walewska R.J., Sun X.M., Dyer M.J., Cohen G.M. Concurrent up-regulation of BCL-XL and BCL2A1 induces approximately 1000-fold resistance to ABT-737 in chronic lymphocytic leukemia. Blood 2009, 113:4403-4413.
8. Boise L.H., Gonzalez-Garcia M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., Thompson C.B. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993, 74:597-608.
9. Cloutier P., Toutant J., Shkreta L., Goekjian S., Revil T., Chabot B. Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-X. J. Biol. Chem. 2008, 283:21315-21324.
10. Garneau D., Revil T., Fisette J.F., Chabot B. Heterogeneous nuclear ribonucleoprotein F/H proteins modulate the alternative splicing of the apoptotic mediator Bcl-X. J. Biol. Chem. 2005, 280:22641-22650.
11. Massiello A., Roesser J., Chalfant C. SAP155 binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5' splice site selection of Bcl-x pre-mRNA. FASEB J. 2006, 20:1680-1682.
12. Paronetto M., Achsel T., Massiello A., Chalfant C., Sette C. The RNA binding protein Sam68 modulates the alternative splicing of Bcl-x. J. Cell Biol. 2007, 176:929-939.
13. Revil T., Toutant J., Shkreta L., Garneau D., Cloutier P., Chabot B. Protein kinase C dependent control of Bcl-X alternative splicing. Mol. Cell. Biol. 2007, 27:8431-8441.
14. Chalfant C., Rathman K., Pinkerman R., Wood R., Obeid L., Ogretmen B., Hannun Y. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. J. Biol. Chem. 2002, 277:12587-12595.
15. Boon-Unge K., Yu Q., Zou T., Zhou A., Govitrapong P., Zhou J. Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism. Chem. Biol. 2007, 14:1386-1392.
16. Moller M., Hertzer K., Wenger T., Herr I., Wink M. The alkaloid emetine as a promising agent for the induction and enhancement of drug induced apoptosis in leukaemia. Oncol. Rep. 2007, 18:737-744.
17. Pettitt A.R., Moran E.C., Cawley J.C. Homotypic interactions protect chronic lymphocytic leukaemia cells from spontaneous death in vitro. Leuk. Res. 2001, 25:1003-1012.
18. Taylor J.K., Zhang Q.Q., Wyatt J.R., Dean N.M. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides. Nat. Biotechnol. 1999, 17:1097-1100.
19. Habens F., Lapham A.S., Dallman C.L., Pickering B.M., Michels J., Marcusson E.G., Johnson P.W., Packham G. Distinct promoters mediate constitutive and inducible Bcl-X(L) expression in malignant lymphocytes. Oncogene 2007, 26:1910-1919.
20. Basanez G., Zhang J., Chau B.N., Maksaev G.I., Frolov V.A., Brandt T.A., Burch J., Hardwick J.M., Zimmerberg J. Pro-apoptotic cleavage products of Bcl-xL form cytochrome c-conducting pores in pure lipid membranes. J. Biol. Chem. 2001, 276:31083-31091.
21. Chen M., Guerrero A.D., Huang L., Shabier Z., Pan M., Tan T.H., Wang J. Caspase-9-induced mitochondrial disruption through cleavage of anti-apoptotic BCL-2 family members. J. Biol. Chem. 2007, 282:33888-33895.
22. Minn A.J., Boise L.H., Thompson C.B. Bcl-x(S) anatagonizes the protective effects of Bcl-x(L). J. Biol. Chem. 1996, 271:6306-6312.
23. Clem R.J., Cheng E.H., Karp C.L., Kirsch D.G., Ueno K., Takahashi A., Kastan M.B., Griffin D.E., Earnshaw W.C., Veliuona M.A., Hardwick J.M. Modulation of cell death by Bcl-XL through caspase interaction. Proc. Natl. Acad. Sci. USA 1998, 95:554-559.
24. Fujita N., Nagahashi A., Nagashima K., Rokudai S., Tsuruo T. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases. Oncogene 1998, 17:1295-1304.
25. Mercatante D.R., Bortner C.D., Cidlowski J.A., Kole R. Modification of alternative splicing of Bcl-X pre-mRNA in prostate and breast cancer cells. Analysis of apoptosis and cell death. J. Biol. Chem. 2001, 276:16411-16417.
26. Mercatante D.R., Mohler J.L., Kole R. Cellular response to an antisense-mediated shift of Bcl-x pre-mRNA splicing and anti-neoplastic agents. J. Biol. Chem. 2002, 277:49374-49382.
27. Zhang Y., Dawson M.I., Mohammad R., Rishi A.K., Farhana L., Feng K.C., Leid M., Peterson V., Zhang X.K., Edelstein M., Eilander D., Biggar S., Wall N., Reichert U., Fontana J.A. Induction of apoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog. Blood 2002, 100:2917-2925.
28. Wang Y., Cheong C.-G., Tanaka Hall T.M., Wang Z. Engineering splicing factors with designed specificities. Nat. Methods 2009, 6:825-830.